Home Clinical Topics Medications

Medications

Osteoarthritis: New trial drug may have powerful anti-inflammatory effect

Researchers from the University of Liverpool, in collaboration with the pharmaceutical company AKL Research & Development, have found a new drug (APPA) that has the potential to treat osteoarthritis, rheumatoid arthritis, and other conditions...

Mindfulness for medication safety

Break the cycle of rushing and multitasking. Takeaways: Patients experience an average of one medication error per day. Many medication errors are related to human factors, including rushing, multitasking, and running on autopilot. Mindfulness strategies...

New findings may help solve the mystery of anesthesia

Despite the everyday use of anesthesia by health professionals, it is still a scientific mystery. Scientists from Scripps Research conducted a study in order to better understand the mechanisms of general anesthetics. Researchers used nanoscale...

Wording of vaccination messaging influences behavior

Washington State University researchers conducted an experiment that studied how differences in messages influenced participants’ attitudes about the human papillomavirus (HPV) vaccine. Nearly 200 participants between the ages of 18 and 29 were studied. Different...

A broader look at insulin

Be sure your knowledge is current. Takeaways: Insulin is a critical part of diabetes management for many people. Insulin types and delivery methods have changed drastically in the last decade. Nurses have an important role...

Infusion therapy: A model for safe practice in the home setting

Careful patient selection, provider and patient education, and well-planned and delivered patient care are critical to success. Takeaways: Home infusion therapy administration is associated with good outcomes but isn’t without risk as patients require an...

Make treatment accessible for opioid use disorder during the COVID-19 pandemic

During the current pandemic Americans are dealing with a complete or near complete disruption of everyday life. It is the same for persons with opioid use disorder (OUD), but they are far from the...

Opioid-induced respiratory depression

Be prepared and know the risks. Takeaways: Risk factors for opioid-induced respiratory depression include impaired rental clearance, high opioid tolerance, and sleep apnea history. Tools for assessing patient sedation levels include Richmond Agitation-Sedation Scale and...
cannabis

New research on possible adverse events to cannabis

A new study recently published in the Journal of Cannabis Research examines the potential “acute adverse reactions” associated with cannabis use. The study examined self-reported adverse reactions from 999 cannabis users and revealed that the...
anesthesia

An overview of neuraxial anesthesia

Please visit the ANA’s website to take the CE: https://www.nursingworld.org/continuing-education/an-overview-of-neuraxial-anesthesia/ Understand the basics so you can effectively manage your patients. Takeaways: Neuraxial anesthesia is the administration of medication into the subarachnoid or epidural space to produce...
cannabis

Cannabinoid hyperemesis syndrome explained

Learn how to identify this frequently misdiagnosed condition. Takeaways: Cannabinoid hyperemesis syndrome is a growing but poorly understood healthcare concern within the rising number of chronic, habitual cannabis users in the United States. Cannabinoid hyperemesis...

New treatment for multiple myeloma

The U.S. Food and Drug Administration (FDA) recently approved Sanofi-Aventis’ Sarclisa (isatuximab-irfc) for the treatment of  adult patients with multiple myeloma. Isatuximab-irfc was previously designated its orphan drug status by the FDA. Isatuximab-irfc was approved...

The changing face of cystic fibrosis

It’s no longer a childhood illness. Takeaways: The Cystic Fibrosis Foundation Patient Data Registry shows that more than 54% of people with cystic fibrosis live 18 years and beyond. Longer life expectancy is due to...